VIRUPAKSHA ORGANICS LIMITED's Insider Trades & SAST Disclosures

VIRUPAKSHA ORGANICS LIMITED's most recent trade in Oxygenta Pharmaceutical Ltd. was a Acquisition of 2,756,500 Equity Shares done at an average price of Rs. 21 . Disclosure was reported to the exchange on May 16, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for VIRUPAKSHA ORGANICS LIMITED in the Trendlyne database.

Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Oxygenta Pharma
VIRUPAKSHA ORGANICS LIMITED Promoter Acquisition 16 May 2025 2,756,500 10,624,858 (28.72%) 7.45% 21 57,886,500 12 May 2025
12 May 2025
Insider Trading Equity Shares Others
Oxygenta Pharma
VIRUPAKSHA ORGANICS LIMITED Promoter Acquisition 26 Apr 2025 5,088,800 7,868,358 (21.28%) 13.76% 21 106,864,800 22 Apr 2025
22 Apr 2025
Insider Trading Equity Shares Others
Oxygenta Pharma
VIRUPAKSHA ORGANICS LIMITED Promoter Acquisition 24 Apr 2025 2,779,340 2,779,558 (7.51%) 7.52% 21 58,366,140 17 Apr 2025
17 Apr 2025
Insider Trading Equity Shares Others
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST